Drug hope: Pfizer happy with trials
Pfizer’s latest HIV drug, maraviroc, doubles the number of people with undetectable levels of HIV compared to the current treatments.
The company revealed half-year results of two advanced trials of maraviroc on patients for whom treatment no longer works.




